Dr. Khurana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Building for Transformative Medicine 10016L
60 Fenwood Road
Boston, MA 02115Phone+1 617-726-2000- Is this information wrong?
Summary
- Vik Khurana is on the faculty at Harvard Medical School and Brigham and Women's Hospital, and a scientific co-Founder of Yumanity Therapeutics. His clinical and research interests relate to neurodegenerative movement disorders, including Parkinson's disease, multiple system atrophy and the cerebellar ataxias. He is a medical graduate of the University of Sydney, Australia, and came to Boston as a Fulbright Scholar and Merck Company Foundation Fellow in 2001, obtaining his Ph.D. in neurobiology from Harvard University in 2006. He completed his residency in Neurology at Brigham and Women's and Massachusetts General Hospitals, and Fellowship training in Movement Disorders and Ataxia at Massachusetts General Hospital. He was a postdoctoral Fellow at the Whitehead Institute/MIT with Susan Lindquist and Rudolf Jaenisch. His research efforts aim to develop novel therapies for neurodegenerative diseases by using diverse model systems including patient-derived stem cells. This work has been supported by funding from the Howard Hughes Medical Institute, the JPB Foundation, and awards from foundations including the American Brain Foundation,Parkinson's Disease Foundations and Multiple System Atrophy coalition . Vik is a member of the Global Multiple System Atrophy Roadmap Consortium and sits on the Board of the MSA Coalition. His recent research has been published in leading journals, including Science, Cell Systems and Cell.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neurology, 2010 - 2012
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2007 - 2010
- Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
- Harvard UniversityPh.D., Neurobiology, 2001 - 2006
- University of Sydney Faculty of MedicineClass of 2000
Certifications & Licensure
- MA State Medical License 2010 - 2025
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients Start of enrollment: 2020 Dec 30
Publications & Presentations
PubMed
- Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies.Sumaiya Nazeen, Xinyuan Wang, Dina Zielinski, Isabel Lam, Erinc Hallacli, Ping Xu, Elizabeth Ethier, Ronya Strom, Camila A Zanella, Vanitha Nithianandam, Dylan Ritter,...> ;Biorxiv. 2024 Mar 7
- The spectrum of neurological presentation in individuals affected by TBL1XR1 gene defects.Amanda Nagy, Francine Molay, Sarah Hargadon, Claudia Brito Pires, Natalie Grant, Lizbeth De La Rosa Abreu, Jin Yun Chen, Precilla D'Souza, Ellen Macnamara, Cynthia Tif...> ;Orphanet Journal of Rare Diseases. 2024 Feb 20
- 1 citationsSequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons.Santhosh Kumar, S., Naseri, N., Pather, S., Hallacli, E., Ndayisaba, A., Buenaventura, C., Acosta, K., Roof, J., Fazelinia, H., Spruce, L., Luk, K., Rhoades, E., Shale...> ;Science Advances. 2024 Feb 9
- Join now to see all
Press Mentions
- A Parkinson’s ‘Game Changer,’ Backed by Michael J. Fox, Could Lead to New Diagnostics and, Someday, TreatmentsApril 12th, 2023
- Peng a Part of Multi-Institutional Research Team to Investigate Parkinson's DiseaseSeptember 16th, 2020
- Two Parkinson’s Organizations Issue a Total of $5.9M in Research GrantsSeptember 19th, 2019
- Join now to see all
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: